Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-14

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for Pramipexole dihydrochloride from Dr. Reddy's Laboratories Limited under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)